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ABSTRACT
A longitudinal, analytical, and treatment
oriented case study is presented describing
the effects of a medication-induced impair
ment of neurological function. The subject is
an elderly, Caucasian, female whose pre
senting symptoms included spasmodic (>yelid
movement: lack of muscle tone and C'ontrol
for specific mu.<icles of the head and neck
repion: generalized hyperactivity: plus dis
tortion of speech and deglutition. Clinical
investigation determined that the subjects
timed relemw antihistamine medication u·as
the primary etiological factor in the presenting
symptoms. Discontinuation of the medication
resulted in a decrease, but not comph•lt•
remission, of the symptoms. Clinical evaluo
tion of the r('sidual speech impairment
included int,•nsiv,· therapy U'hich u•as only
minimally successful in reducing proposi
tional speech distortion. The patients
neuropathy was inferred to be .<iuprabu/bar in
site as a result of the• speech analysis u•hieh is
deseribed as a reliable diagnostic aid in
evaluation of severity of this type of neuro
logical pathology. During the eight years of
observation of this subject, documentation of
the impairment u·as made by means of various
media. Some of th,• resull<i of this documen
tation accompany the study.

INTRODUCTION

The person of this report devel
oped spasmodic dystonia in the
lower bulbar (CN 7, 9, 10 and 12)
and the cervical motor innervations
during prolonged chlorphenira
mine medication (Thach et al,
1975). The dystonia resembled
that which may be induced by
neuroleptic medications, particu
larly those of the phenothiazine
lllu.strations by
Mrs. Diane Robertson Murayama

series (Crane, 1968 and 1973:
Crane· and Gardner, 1968; Crane
· and Naranjo, 1971; Chase, 1972).
Like those, it has continued in an
essentially consistent pattern,
with distortions of speech and of
mature pattern of feeding. The
elementary performances of swal
low, suckle, tidal respiration and
maintenance of the pharyngeal
airway were spared.
We report cinephotographic,
cineradiographic and acoustic
spectrographic observations of a
particular pattern of dystonia of
the mouth, pharynx and larynx
and of abrupt darting motions of
the tongue which are related in
their occasions to voluntary per
formances.. The details of their
interactions with speech are par
ticularly strategic as criteria of
identification and of demonstra
tion of this dyskinesia pattern.

CLINICAL HISTORY

The person of this report, a
woman of 65 years, was referred to
the Clinical Center, NIH, in
Novem her, 1971 for evaluation of
involuntary facial movements of
three years duration. In the Fall of
1965 she was given a prescription
for a timed release capsule con
taining chlorpheniramine maleate
8 mg., phenylpropanolamine 50
mg. and isopropamide 2.5 mg.• for
treatment of allergic rhinitis. The
medication was continued without

prescription. Within one year she
began taking the capsules twice
per day prophylactically. She was
taking talbutal (5-allyl-5 secbutyl
barbituric acid) 120 mg. each
evening for insomnia from Feb
ruary, 1967. She was also taking
chlordiazepoxide H C1 (10 mg.
twice weekly) for nervous tension.
She had taken dexamphetamine
for six weeks in 1963 for weight
control but had no further exposure
to amphetamines or neuroleptic
drugs (including phenothiazines)
prior to onset of symptoms.
In the Fall of 1968 she developed
blepharospasm, which continued
in increasing but irregular inci
dence and severity; it was increased
by conjunctiva! irritation, as from
dust or soap. In 1970 she had
involuntary opening of the mouth.
Her speech gradually became less
intelligible. Drooling, ch_oking while
swallowing and nasal regurgitation
of liquids began in 1971 and in
creased to severely impair feeding.
These impairments were increased
by anxiety or fatigue and dis
appeared during sleep. Tranquil
izing drugs (chlordiazepoxide HCl,
diazepan), reserpine (40 mg. a day
for eight weeks) and haldol (3 mg.
X 3 for 10 days) produced no
lasting change in her neurological
impairment.
Her health was generally good
throughout her lifetime. She was
severely ill without neurological
symptoms in 1918 for three days
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